This article needs additional citations for verification. (March 2010)
|Adolf Merckle, founder |
Oliver Windholz, CEO
|Products||Pharmaceuticals and generic medication.|
|Revenue||€ 1.8 billion (2007)|
Number of employees
|Parent||Teva Pharmaceutical Industries|
Ratiopharm was owned by Adolf Merckle and makes generic pharmaceuticals. They are based in Ulm, Germany, with products being distributed[clarification needed] in over 35 countries worldwide.
Since June 2017, the company has been managed by Christoph Stoller, General Manager of Teva Germany and Austria (European headquarters). He succeeded Markus Leyck Dieken, who was General Manager from October 2013 and joined the Teva Group Management in June 2017. Previously, Sven Dethlefs, who oversaw the takeover of Ratiopharm by Teva in 2010, held the position for five years until he moved to the group management in Israel in 2013.
- NATASHA SINGER (March 18, 2010). "Teva to Acquire Top German Generics Maker for $5 Billion". The New York Times. Retrieved March 18, 2010.
- Teva to Acquire Generics Firm The Wall Street Journal March 19, 2010
- "Teva Completes Acquisition of Ratiopharm". August 10, 2010. Archived from the original on August 18, 2010. Retrieved August 20, 2010.
- Zeitung, Neu-Ulmer. "Ratiopharm: Der neue Chef am Standort Ulm". Augsburger Allgemeine (in German). Retrieved 2022-09-16.
- Zeitung, Neu-Ulmer. "Ratiopharm: Der neue Chef am Standort Ulm". Augsburger Allgemeine (in German). Retrieved 2022-08-19.